{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:21:41Z","timestamp":1786119701316,"version":"build-2736575974"},"reference-count":31,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1097\/md.0000000000006441","type":"journal-article","created":{"date-parts":[[2017,3,22]],"date-time":"2017-03-22T18:24:46Z","timestamp":1490207086000},"page":"e6441","source":"Crossref","is-referenced-by-count":27,"title":["Head-to-head comparison of 11C-PiB and 18F-FC119S for A\u03b2 imaging in healthy subjects, mild cognitive impairment patients, and Alzheimer's disease patients"],"prefix":"10.1097","volume":"96","author":[{"given":"Byung Hyun","family":"Byun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Byung Il","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Su Yeon","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"In Ok","family":"Ko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyo Chul","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyeong Min","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu Kyeong","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun-Young","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seon Hee","family":"Bu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jung Hwa","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dae Yoon","family":"Chi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeong Ho","family":"Ha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang Moo","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-58-20210226","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/00002093-200304000-00002","article-title":"The magnitude of dementia occurrence in the world","volume":"17","author":"Wimo","year":"2003","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"R2-58-20210226","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1212\/WNL.41.4.479","article-title":"The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease","volume":"41","author":"Mirra","year":"1991","journal-title":"Neurology"},{"key":"R3-58-20210226","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1212\/01.wnl.0000261919.22630.ea","article-title":"Imaging beta-amyloid burden in aging and dementia","volume":"68","author":"Rowe","year":"2007","journal-title":"Neurology"},{"key":"R4-58-20210226","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1002\/ana.20009","article-title":"Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B","volume":"55","author":"Klunk","year":"2004","journal-title":"Ann Neurol"},{"key":"R5-58-20210226","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.cpet.2009.12.008","article-title":"Amyloid PET ligands for dementia","volume":"5","author":"Villemagne","year":"2010","journal-title":"PET Clin"},{"key":"R7-58-20210226","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.2967\/jnumed.109.065284","article-title":"Preclinical properties of 18F-AV-45: a PET agent for Abeta plaques in the brain","volume":"50","author":"Choi","year":"2009","journal-title":"J Nucl Med"},{"key":"R9-58-20210226","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.nucmedbio.2005.06.001","article-title":"F-18 Polyethyleneglycol stilbenes as PET imaging agents targeting Abeta aggregates in the brain","volume":"32","author":"Zhang","year":"2005","journal-title":"Nucl Med Biol"},{"key":"R11-58-20210226","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1007\/s00259-012-2088-x","article-title":"Comparison of 11C-PiB and 18F-florbetaben for Abeta imaging in ageing and Alzheimer's disease","volume":"39","author":"Villemagne","year":"2012","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R12-58-20210226","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1007\/s00259-013-2564-y","article-title":"[18F]Flutemetamol amyloid-beta PET imaging compared with [11C]PIB across the spectrum of Alzheimer's disease","volume":"41","author":"Hatashita","year":"2014","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R13-58-20210226","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1007\/s00259-014-2753-3","article-title":"Amyloid PET imaging in Alzheimer's disease: a comparison of three radiotracers","volume":"41","author":"Landau","year":"2014","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R14-58-20210226","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1001\/jama.2010.2008","article-title":"Use of florbetapir-PET for imaging beta-amyloid pathology","volume":"305","author":"Clark","year":"2011","journal-title":"JAMA"},{"key":"R15-58-20210226","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/S1474-4422(11)70077-1","article-title":"Cerebral amyloid-beta PET with florbetaben (18F) in patients with Alzheimer's disease and healthy controls: a multicentre phase 2 diagnostic study","volume":"10","author":"Barthel","year":"2011","journal-title":"Lancet Neurol"},{"key":"R16-58-20210226","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1002\/ana.22068","article-title":"18F-flutemetamol amyloid imaging in Alzheimer disease and mild cognitive impairment: a phase 2 trial","volume":"68","author":"Vandenberghe","year":"2010","journal-title":"Ann Neurol"},{"key":"R17-58-20210226","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1016\/j.bmc.2016.03.034","article-title":"Synthesis and evaluation of 6-(3-[(18)F]fluoro-2-hydroxypropyl)-substituted 2-pyridylbenzothiophenes and 2-pyridylbenzothiazoles as potential PET tracers for imaging Abeta plaques","volume":"24","author":"Lee","year":"2016","journal-title":"Bioorg Med Chem"},{"key":"R18-58-20210226","first-page":"S1","article-title":"Quantification of amyloid-\u03b2deposition using 18F-FC119S PET in human brains: a phase 0-1 study. EANM\u201915, 28th Annual EANM Congress of the European Association of Nuclear Medicine 2015, 10-14 October 2015, Hamburg, Germany","volume":"42","author":"Byun","year":"2015","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R19-58-20210226","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","article-title":"\u201cMini-mental state\u201d. A practical method for grading the cognitive state of patients for the clinician","volume":"12","author":"Folstein","year":"1975","journal-title":"J Psychiatr Res"},{"key":"R20-58-20210226","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1212\/WNL.43.11.2189","article-title":"Can sensory stimulation improve the functional outcome in stroke patients?","volume":"43","author":"Johansson","year":"1993","journal-title":"Neurology"},{"key":"R21-58-20210226","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/j.1365-2796.2004.01380.x","article-title":"Mild cognitive impairment\u2014beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment","volume":"256","author":"Winblad","year":"2004","journal-title":"J Intern Med"},{"key":"R22-58-20210226","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1212\/WNL.34.7.939","article-title":"Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease","volume":"34","author":"McKhann","year":"1984","journal-title":"Neurology"},{"key":"R23-58-20210226","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1006\/nimg.2001.0978","article-title":"Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain","volume":"15","author":"Tzourio-Mazoyer","year":"2002","journal-title":"Neuroimage"},{"key":"R24-58-20210226","doi-asserted-by":"crossref","first-page":"880","DOI":"10.2967\/jnumed.112.114785","article-title":"Head-to-head comparison of 11C-PiB and 18F-AZD4694 (NAV4694) for beta-amyloid imaging in aging and dementia","volume":"54","author":"Rowe","year":"2013","journal-title":"J Nucl Med"},{"key":"R25-58-20210226","doi-asserted-by":"crossref","first-page":"932","DOI":"10.2967\/jnumed.113.133793","article-title":"Quantitative analysis of amyloid deposition in Alzheimer Disease using PET and the radiotracer (1)(1)C-AZD2184","volume":"55","author":"Ito","year":"2014","journal-title":"J Nucl Med"},{"key":"R26-58-20210226","doi-asserted-by":"crossref","first-page":"5768","DOI":"10.1088\/0031-9155\/61\/15\/5768","article-title":"Automated PET-only quantification of amyloid deposition with adaptive template and empirically pre-defined ROI","volume":"61","author":"Akamatsu","year":"2016","journal-title":"Phys Med Biol"},{"key":"R27-58-20210226","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.neuint.2008.12.016","article-title":"[(11)C]PIB-amyloid binding and levels of Abeta40 and Abeta42 in postmortem brain tissue from Alzheimer patients","volume":"54","author":"Svedberg","year":"2009","journal-title":"Neurochem Int"},{"key":"R28-58-20210226","doi-asserted-by":"crossref","first-page":"913","DOI":"10.2967\/jnumed.109.069088","article-title":"In vivo imaging of amyloid deposition in Alzheimer disease using the radioligand 18F-AV-45 (flobetapir F 18)","volume":"51","author":"Wong","year":"2010","journal-title":"J Nucl Med"},{"key":"R29-58-20210226","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.2967\/jnumed.111.089730","article-title":"Amyloid imaging with 18F-florbetaben in Alzheimer disease and other dementias","volume":"52","author":"Villemagne","year":"2011","journal-title":"J Nucl Med"},{"key":"R30-58-20210226","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1136\/jnnp-2012-302548","article-title":"Amyloid imaging in Alzheimer's disease: comparison of florbetapir and Pittsburgh compound-B positron emission tomography","volume":"83","author":"Wolk","year":"2012","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R31-58-20210226","doi-asserted-by":"crossref","first-page":"70","DOI":"10.2967\/jnumed.112.109009","article-title":"Amyloid-beta imaging with Pittsburgh compound B and florbetapir: comparing radiotracers and quantification methods","volume":"54","author":"Landau","year":"2013","journal-title":"J Nucl Med"},{"key":"R32-58-20210226","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1007\/s00259-013-2620-7","article-title":"Imaging of amyloid deposition in human brain using positron emission tomography and [18F]FACT: comparison with [11C]PIB","volume":"41","author":"Ito","year":"2014","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R33-58-20210226","doi-asserted-by":"crossref","first-page":"995","DOI":"10.3233\/JAD-2010-100222","article-title":"Clinically different stages of Alzheimer's disease associated by amyloid deposition with [11C]-PIB PET imaging","volume":"21","author":"Hatashita","year":"2010","journal-title":"J Alzheimers Dis"},{"key":"R34-58-20210226","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1212\/01.wnl.0000219668.47116.e6","article-title":"Neuropathology of older persons without cognitive impairment from two community-based studies","volume":"66","author":"Bennett","year":"2006","journal-title":"Neurology"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000006441","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:47:36Z","timestamp":1786042056000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00005792-201703240-00058"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3]]},"references-count":31,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000006441","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2017,3]]}}}